ATEMPT 2.0: Adjuvant T-DM1 vs TH

NCT04893109 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-positive Breast Cancer

Interventions

DRUG: trastuzumab-emtansine
DRUG: Trastuzumab SC
DRUG: Paclitaxel

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]